WAYNE, Pa., Sept. 26, 2014 /PRNewswire/ -- Ryan &
Maniskas, LLP is investigating potential claims against the board
of directors of LipoScience, Inc. ("LipoScience" or the "Company")
(NASDAQ: LPDX) concerning possible breaches of fiduciary duty and
other violations of law related to the Company's efforts to sell
the Company to Laboratory Corporation of America Holdings in a
transaction valued at approximately $85.3
million.
If you own shares of LipoScience and would like to learn more
about this class action or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/lpdx. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the agreement, shareholders of LipoScience
would receive $5.25 in cash for each
share of LipoScience they own.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by the Board of Directors of
LipoScience for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT:
Ryan & Maniskas, LLP
Richard
A. Maniskas, Esquire
995 Old Eagle School Rd.,
Suite 311
Wayne, PA
19087
877-316-3218
www.rmclasslaw.com/cases/lpdx
rmaniskas@rmclasslaw.com
Logo -
http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
SOURCE Ryan & Maniskas, LLP